Optimization and evaluation of Lisinopril mucoadhesive sustained release matrix pellets: In-vitro and ex-vivo studies

Lisinopril (LIS) is antihypertensive drug, classified as a class III drug with high water solubility and low permeability. To overcome the low permeability, 32 factorial designs aimed to formulate LIS as a sustained-release (LIS-SR) matrix pellet by extrusion/spheronization. Matrix pellets were comp...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Modhi F. Alagili, Bushra T. AlQuadeib, Lubna Y. Ashri, Mohamed Abbas Ibrahim
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Springer 2023-08-01
Sarja:	Saudi Pharmaceutical Journal
Aiheet:	Lisinopril Oral delivery Pellets Extrusion/spheronization In vitro and ex vivo characterization
Linkit:	http://www.sciencedirect.com/science/article/pii/S1319016423001858
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!